Modulated T-complex protein 1 ζ and peptidyl-prolyl cis-trans isomerase B are two novel indicators for evaluating lymph node metastasis in colorectal cancer: Evidence from proteomics and bioinformatics

Proteomics - Clinical Applications

Volumn 3, Issue 10, 2009, Pages 1225-1235

  Yue, Fei ^a   Wang, Li Shun ^a   Xia, Li ^a   Wang, Xiao Ling ^a   Feng, Bo ^a   Lu, Ai Guo ^a   Chen, Guo Qiang ^a,b   Zheng, Min Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE   (China)

Author keywords

Bioinformatics; Colorectal cancer; Lymph node metastasis; Peptidyl prolyl cis trans isomerase B; T complex protein 1 subunit

Indexed keywords

GALECTIN 3; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA1; KERATIN; LACTOYLGLUTATHIONE LYASE; LEUKOCYTE ELASTASE INHIBITOR; ONCOPROTEIN; PEPTIDYLPROLYL ISOMERASE; PREALBUMIN; PROTEASOME; RETINAL DEHYDROGENASE; T COMPLEX PROTEIN 1 ZETA SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUPPORT VECTOR MACHINE; UPREGULATION; WESTERN BLOTTING;

EID: 70350784327     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200900028     Document Type: Article

References (41)

1. Bingham, S., Riboli, E., Diet and cancer - the European prospective investigation into cancer and nutrition. Nat. Rev. Cancer 2004, 4, 206-215.
2. Sung, J. J., Lau, J. Y., Goh, K. L., Leung, W. K., Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005, 6, 871-876.
3. Winawer, S., Faivre, J., Selby, J., Bertaro, L. et al., Work-group II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann. Oncol. 2005, 16, 31-33.
4. Kim, H. J., Yu, M. H., Kim, H., Byun, J., Lee, C., Noninvasive molecular biomarkers for the detection of colorectal cancer. Biochem Mol. Biol. Rep. 2008, 41, 685-692.
5. Ramos, M., Esteva, M., Cabeza, E., Campillo, C. et al., Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur. J. Cancer 2007, 43, 2467-2478.
6. Ramos, M., Esteva, M., Cabeza, E., Llobera, J., Ruiz, A., Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur. J. Cancer 2008, 44, 510-521.
7. Bembenek, A., Gretschel, S., Schlag, P. M., Sentinel lymph node biopsy for gastrointestinal cancers. J. Surg. Oncol. 2007, 96, 342-352.
8. Chau, I., Chan, S., Cunningham, D., Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives. Clin. Colorectal Cancer 2003, 3, 19-33.
9. Rodriguez-Bigas, M. A., Maamoun, S., Weber, T. K., Penetrante, R. B. et al., Clinical significance of colorectal cancer: metastases in lymph nodes<5mm in size. Ann. Surg. Oncol. 1996, 3, 124-130.
10. Sarli, L., Bader, G., Iusco, D., Salvemini, C. et al., Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur. J. Cancer 2005, 41, 272-279.
11. Cahill, R. A., Leroy, J., Marescaux, J., Could lymphatic mapping and sentinel node biopsy provide oncological providence for local resectional techniques for colon cancer? A review of the literature. Biomed Chromatogr. Surg. 2008, 8, 17.
12. Pei, H., Zhu, H., Zeng, S., Li, Y. et al., Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 2007, 6, 2495-2501.
13. Wu, C. C., Chen, H. C., Chen, S. J., Liu, H. P. et al., Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008, 8, 316-332.
14. Greene, F. L., Page, D. L., Fleming, I. D., Fritz, A. et al., AJCC Cancer Staging Handbook, Springer, New York 2002.
15. Ilyas, M., Hao, X. P., Wilkinson, K., Tomlinson, I. P. et al., Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut 1998, 43, 383-387.
16. Rodriguez-Pineiro, A. M., Rodriguez-Berrocal, F. J., Paez de la Cadena, M., Improvements in the search for potential biomarkers by proteomics: application of principal component and discriminant analyses for two-dimensional maps evaluation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 849, 251-260.
17. Byvatov, E., Schneider, G., Support vector machine applications in bioinformatics. Appl. Bioinformatics 2003, 2, 67-77.
18. Vapnik, V. N., An overview of statistical learning theory. IEEE Trans. Neural Netw. 1999, 10, 988-999.
19. Hatakeyama, H., Kondo, T., Fujii, K., Nakanishi, Y. et al., Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6, 6300-6316.
20. Fujii, K., Kondo, T., Yokoo, H., Yamada, T. et al., Protein expression pattern distinguishes different lymphoid neoplasms. Proteomics 2005, 5, 4274-4286.
21. Seike, M., Kondo, T., Fujii, K., Okano, T. et al., Proteomic signatures for histological types of lung cancer. Proteomics 2005, 5, 2939-2948.
22. Seike, M., Kondo, T., Fujii, K., Yamada, T. et al., Proteomic signature of human cancer cells. Proteomics 2004, 4, 2776-2788.
23. Yokota, S., Yamamoto, Y., Shimizu, K., Momoi, H. et al., Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 2001, 6, 345-350.
24. Coghlin, C., Carpenter, B., Dundas, S. R., Lawrie, L. C. et al., Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J. Pathol. 2006, 210, 351-357.
25. Spiess, C., Miller, E. J., McClellan, A. J., Frydman, J., Identification of the TRiC/CCT substrate binding sites uncovers the function of subunit diversity in eukaryotic chaperonins. Mol. Cell 2006, 24, 25-37.
26. Steinmann, B., Bruckner, P., Superti-Furga, A., Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J. Biol. Chem. 1991, 266, 1299-1303.
27. Kruse, M., Brunke, M., Escher, A., Szalay, A. A. et al., Enzyme assembly after de novo synthesis in rabbit reticulocyte lysate involves molecular chaperones and immunophilins. J. Biol. Chem. 1995, 270, 2588-2594.
28. Rycyzyn, M. A., Clevenger, C. V., The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc. Natl. Acad. Sci. USA 2002, 99, 6790-6795.
29. Fang, F., Flegler, A. J., Du, P., Lin, S., Clevenger, C. V., Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am. J. Pathol. 2009, 174, 297-308.
30. Lim, S. O., Park, S. J., Kim, W., Park, S. G. et al., Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2002, 291, 1031-1037.
31. Campa, M. J., Wang, M. Z., Howard, B., Fitzgerald, M. C., Patz, E. F., jr., Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res. 2003, 63, 1652-1656.
32. Yang, H., Chen, J., Yang, J., Qiao, S. et al., Cyclophilin A is up-regulated in small cell lung cancer and activates ERK1/2 signal. Biochem. Biophys. Res. Commun. 2007, 361, 763-767.
33. Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., Li, D., Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004, 64, 9018-9026.
34. Mikuriya, K., Kuramitsu, Y., Ryozawa, S., Fujimoto, M. et al., Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 2007, 30, 849-855.
35. Li, Z., Zhao, X., Bai, S., Wang, Z. et al., Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol. Cell. Proteomics 2008, 7, 1810-1823.
36. Ward, B. K., Mark, P. J., Ingram, D. M., Minchin, R. F., Ratajczak, T., Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 1999, 58, 267-280.
37. Meza-Zepeda, L. A., Forus, A., Lygren, B., Dahlberg, A. B. et al., Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 2002, 21, 2261-2269.
38. Leung, K. W., Tsai, C. H., Hsiao, M., Tseng, C. J. et al., Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma. Oncol. Rep. 2009, 21, 1097-1104.
39. Wiegand, S., Dakic, B., Rath, A. F., Makarova, G. et al., The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas. Oral. Oncol. 2009, doi: 10.1016/j.oraloncology.2009.04.006, in press.
40. Choi, K. J., Piao, Y. J., Lim, M. J., Kim, J. H. et al., Over-expressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Res. 2007, 67, 3654-3662.
41. Lu, K. P., Suizu, F., Zhou, X. Z., Finn, G. et al., Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol. Carcinog. 2006, 45, 397-402.